World AMR Awareness Week 2026: The Strategic Role of Vaccines in Combating Antimicrobial Resistance
18–24 November 2026 | One Health, One Action: Prevent AMR Now
World AMR Awareness Week 2026, observed from 18 to 24 November, highlights the urgent need for coordinated global action against antimicrobial resistance (AMR). This year's theme, “One Health, One Action: Prevent AMR Now,” emphasizes the interconnectedness of human, animal, plant and environmental health and the importance of collaborative approaches to preventing the emergence and spread of drug-resistant infections.
Antimicrobial resistance occurs when microorganisms develop the ability to withstand medicines designed to control or eliminate them. Its growing prevalence threatens the effectiveness of treatments, increases healthcare costs and poses significant challenges to public health, animal health and food security.
Vaccines: A Preventive Strategy Against Antimicrobial Resistance
Alongside accurate diagnosis, responsible antimicrobial use and strengthened surveillance systems, vaccination represents a major preventive tool in reducing infectious diseases and the need for antimicrobial treatments.
By preventing infections, reducing pathogen transmission and limiting disease complications, vaccines can contribute to lower antibiotic consumption and reduce the selective pressure that drives antimicrobial resistance. The development of innovative vaccines and improved access to effective immunization are therefore important components of global AMR prevention strategies.
From One Health to an Innovative Vaccine Ecosystem
Sustainable action against antimicrobial resistance requires an approach that extends beyond human healthcare. The close relationship between human, animal and environmental health highlights the importance of interdisciplinary research, coordinated policies and technological innovation.
In this context, novel vaccine platforms, advanced manufacturing technologies, innovative diagnostic methods, pathogen surveillance and stronger collaboration among research institutions, universities, industry and policymakers are essential.
The 1st International Congress of Vaccine and Vaccination (ICVV 2026), centered on One Health and vaccine innovation, provides an international platform for scientific exchange and collaboration among researchers, specialists, policymakers and vaccine industry stakeholders.
Addressing the relationship between vaccination, infectious disease prevention and antimicrobial resistance is an important part of shaping the future of immunization systems and strengthening preparedness against emerging and re-emerging health threats.
Advancing Collaboration Across Science, Technology and Policy
World AMR Awareness Week 2026 reinforces an essential message: preserving the effectiveness of antimicrobial medicines requires more than treatment alone. Infection prevention, vaccine development, timely diagnosis, continuous surveillance and cross-sector collaboration must be central to global AMR strategies.
The future of AMR prevention depends on connecting science, vaccination, innovation and collective action through the One Health approach.